NCT05720130
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05720130
Title Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Castration Resistant Prostate Cancer (TheraPb - Phase I/II Study).
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors AdvanCell Pty Limited
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS


No variant requirements are available.